LOY-002 overview
LOY-002: The First FDA Dog Longevity Drug
LOY-002 is a daily tablet program for senior dogs, with public updates indicating efficacy and safety sections accepted and manufacturing review still in progress. Conditional approval could potentially land in late 2026 to 2027 depending on review.
Who may qualify?
- Senior dogs around 10+ years old
- Dogs 14+ lbs
- Final criteria depend on eventual FDA label language and veterinary guidance
Get LOY-002 timeline alerts
Join the list to get milestone alerts and potential availability updates.
Want the full tracker? View the complete longevity drug hub.